Director, Strategic Alliances & External Engagement – Medical Affairs

Role Summary

The Director of Strategic Alliances & External Engagement is a senior leader within Medical Affairs responsible for developing and executing a cross-functional coordinated engagement strategy that strengthens Mineralys’ scientific leadership in cardio-renal-metabolic disorders. This role drives collaboration across academic institutions, professional societies, patient advocacy organizations, and other key external stakeholders to support the full product lifecycle of lorundrostat, Mineralys’ first-in-class aldosterone synthase inhibitor. By aligning external partnerships with the company’s medical and corporate objectives, this leader ensures that actionable insights, scientific data, and real-world evidence shape how Mineralys advances its mission to improve outcomes for patients with uncontrolled and resistant hypertension.

Responsibilities

• Forge and manage strategic partnerships.
• Identify, evaluate, and cultivate high-impact relationships with leading academic investigators, clinical networks, professional societies, and patient advocacy groups within the hypertension and broader CRM community.
• Build collaborative frameworks that expand scientific exchange, facilitate data generation, and amplify Mineralys’ visibility in the field.

• Lead the external engagement strategy and cultivate scientific thought leadership
• Design and implement an integrated engagement roadmap aligned with Medical Affairs pillars, Scientific Communication Platform, and corporate objectives.
• Partner closely with field medical, scientific communications, HEOR, and clinical development teams to ensure coordinated and compliant interactions.
• Lead external collaborations with Key Opinion Leaders (KOLs), digital opinion leaders (DOLs), and academic consortia to deepen understanding of aldosterone-driven disease mechanisms and treatment paradigms.
• Integrate scientific and clinical insights into medical strategies, field guidance, and future development planning.

• Clinical practice guideline oversight
• Serve as the Medical Affairs lead for guideline and compendia inclusion strategy, aligning internal evidence generation, publication planning, and external KOL engagement to meet evidence thresholds for consideration.
• Build and sustain strategic alliances with key guideline committees, scientific societies, and evidence-based medicine organizations to advocate for inclusion of lorundrostat-related data.

• Plan and execute advisory board meetings
• Design, plan, and execute compliant scientific advisory board meetings (virtual and in-person) to obtain actionable insights that inform Medical Affairs strategy, evidence generation, and external engagement priorities.
• Identify, recruit, and collaborate with key external experts and thought leaders across hypertension, nephrology, and cardiometabolic specialties to ensure diverse, high-quality scientific input.
• Develop clear strategic objectives, discussion guides, and post-meeting analysis to translate insights into tangible actions supporting launch readiness, guideline inclusion, and value communication.
• Partner cross-functionally with Compliance, Legal, and Commercial stakeholders to ensure all activities align with corporate governance and OIG standards for external scientific interactions.

• Oversee engagement strategy with professional organizations
• Develop and lead the strategic engagement plan with key professional societies and scientific organizations to strengthen Mineralys’ external scientific presence and credibility within the cardio-renal-metabolic community.
• Oversee planning and execution of scientific sponsorships and society collaborations, ensuring alignment with Medical Affairs objectives, evidence dissemination priorities, and compliance standards.
• Partner cross-functionally with synchronizing congress strategy, data releases, and post-meeting insight capture.

• Patient Advocacy initiatives
• Establish and maintain strategic partnerships with patient advocacy organizations to align on shared goals of disease awareness, education, and equitable access to emerging therapies.
• Collaborate with patient advocacy organizations to ensure the patient voice informs clinical development, access strategies, and educational initiatives.

• Medical Grants management
• Oversee the Medical Affairs grants, sponsorships, and external funding process, ensuring fair, transparent, and compliant review and execution of educational and scientific support requests.

• Drive cross functional alignment
• Partner with Clinical Development, R&D, Commercial, Regulatory, and Legal to ensure consistent, compliant, and science-based communication.
• Serve as an internal ambassador for external engagement excellence, ensuring collaboration is strategic and measured by clear KPIs.
• Ensure compliance and excellence
• Establish and uphold the highest ethical standards in external engagement, consistent with corporate compliance policies, PhRMA guidelines, and global regulations.
• Develop and refine SOPs and best practices for compliant collaboration and sponsorship activities.

Qualifications

• Advanced scientific or clinical degree (PharmD, PhD, MD, or equivalent) required.
• 8+ years of experience in Medical Affairs or related functions within the biopharmaceutical industry, including experience leading external collaborations or alliance management.
• Therapeutic area expertise in cardiovascular, renal, endocrine, or metabolic diseases preferred.
• Strategic and analytical mindset with a proven ability to translate external insights into actionable medical strategies.
• Strong leadership and influence skills—able to build trust, align cross-functional teams, and drive execution in a matrix environment.
• Excellent communication and presentation skills, including experience representing the organization at scientific meetings and external forums.
• Comprehensive understanding of compliance and regulatory frameworks governing scientific exchange and industry collaborations.

Travel

Travel approximately ~20–30%, including domestic and occasional international travel to scientific congresses, investigator meetings, advisory boards, field team visits, Medical Affairs planning sessions, and cross-functional onsite meetings.